Additional Resources

Clinical Trials

National Institute of Health. Clinical Trials.

Soft Tissue Sarcoma Treatment Guidelines

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma. Version 2.2019.

Education and Research

American Cancer Society.

American Society of Clinical Oncology (ASCO).

Connective Tissue Oncology Society.

Sarcoma Alliance for Research through Collaboration (SARC).


Relevant Journals

Oncology. CancerNetwork.


Nature Reviews Cancer.

American Cancer Society: Cancer Facts and Figures 2018. Atlanta, GA: American Cancer Society, 2018. Accessed November 28, 2018.

American Cancer Society. Survival by Stage of Soft Tissue Sarcoma.

Blay J. Getting up-to-date in the management of soft tissue sarcoma. Future Oncol. 2018;14:3-13.

Blay J. Intensity of recent years in the investigation of soft tissue sarcoma. Future Oncol. 2017;13:3-9.

Blay J, Soibinet P, Penel N; NETSARC/RREPS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) networks. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28:2852-2859.

Demetri G, von Mehren M, Jones R, et al. Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a Phase III randomized multicenter clinical trial. J Clin Oncol. 2016;34:786-793.

In G, Hu J, Tseng W. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical consideration. Ther Adv Med Oncol. 2017;9:533-550.

National Cancer Institute. Adult Soft Tissue Sarcoma Treatment (PDQ) – Health Professional Version. Accessed March 14, 2019.

Pollack RE, Maki RG, Baldini EH, et al. Soft tissue sarcoma of the trunk and extremities. In: Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer, 2017, pp 531-537.

Rothermundt C, Whelan JS, Dileo P, et al.: What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 2014;110:2420-2426.

Schöffski P, Chawla S, Maki R, et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, Phase 3 trial. Lancet. 2016;387:1629-1637.

SEER Cancer Stat Facts: Soft Tissue including Heart Cancer. National Cancer Institute. Bethesda, MD. Accessed March 14, 2019.

Seetharam M, Kolla K, Chawla S. Metastatic Soft Tissue Sarcomas: A Review of Treatments and New Pharmacotherapies. Clin Oncol. 2018;3: Article1426.

Siegel R, Miller K, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.

Tap W, Jones R, Van Tine B, et al. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomized phase 2 trial. Lancet. 2016;388:488-497.

Yoon SS, Maki RG, Asare EA, et al. Soft tissue sarcoma of the trunk and extremities. In: Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer, 2017, pp 507-515.

The following list includes websites and articles with comprehensive information about soft tissue sarcoma. We encourage you to read these and other sites to learn more about your disease. It is also important to speak openly with your doctor about the specifics of your cancer to find out what treatment options are available to you.

American Cancer Society.

National Cancer Institute.

National Comprehensive Cancer Network.



Sarcoma Alliance.

Patient Power.

Toolkit Intro





Additional Resources

Clinical Care Toolkit 0%

Your progress:

Patient Toolkit 0%

Your progress: